QDII

CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again

Retrieved on: 
Sunday, November 13, 2022

HONG KONG, Nov 14, 2022 - (ACN Newswire) - China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022.

Key Points: 
  • HONG KONG, Nov 14, 2022 - (ACN Newswire) - China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022.
  • The inclusion of the Group in the MSCI China Index reaffirms the market's recognition of the Group's business development.
  • China Resources Pharmaceutical Group Limited ("CR Pharm", stock code: 3320) is a leading integrated pharmaceutical company in China.
  • CR Pharm is one of the largest pharmaceutical enterprises (manufacturing 600 products), the largest manufacturer of over-the-counter drugs and the third largest distributor of pharmaceutical products in China.

GTJAI Successfully Launched "China Funds Festival" Live Broadcast

Retrieved on: 
Thursday, October 27, 2022

Mr. GAN Tian, Chief Executive Officer of ChinaAMC Funds (Hong Kong), said, "in recent years, the international environment has been turbulent.

Key Points: 
  • Mr. GAN Tian, Chief Executive Officer of ChinaAMC Funds (Hong Kong), said, "in recent years, the international environment has been turbulent.
  • Nevertheless, ChinaAMC Funds (Hong Kong) has been able to seize opportunities and launch innovative products despite the complex environment.
  • CSOP's team consists of nearly 80 professionals and clients around the world include sovereign wealth funds, pension/retirement funds, insurance companies, family offices, and banks.
  • E Fund possesses provision of asset management services including China mutual funds, social security funds, pension insurance funds, corporate pension funds, segregated accounts, QDII, and for global investors: QFII, RQFII.

GF Holdings (Hong Kong) Awarded "Structured Products (China Greater Bay Area)" and "Structured Products Provider of the Year (China Greater Bay Area)" by Bloomberg Businessweek

Retrieved on: 
Friday, August 13, 2021

Global Markets - GF Hong Kong, which has won the excellence awards, is committed to building a professional platform for cross-border financial products focusing on the Greater Bay Area.

Key Points: 
  • Global Markets - GF Hong Kong, which has won the excellence awards, is committed to building a professional platform for cross-border financial products focusing on the Greater Bay Area.
  • It has launched a series of ground-breaking diversified cross-border structured products, leading the product innovation in the market.
  • Some of them has fathered the creation of cross-border swap solutions, pioneering the blooming of cross-border structured products in China."
  • For six consecutive years from 2015 to 2020, GF Securities ranked in the forefront of "Hurun's Top Brands List" amongst listed Chinese securities companies.